Copy Number-low/TP53-mutated Endometrial Cancer With Wild-type p53 Immunoexpression: Implications for Risk Stratification and Management When Using Next-generation Sequencing for Molecular Classification

Modern Pathology 2026

View at publisher

Authors: Joseph T. Rabban, Rebecca J. Wolsky, Neslihan Kayraklioglu, Kurtis D. Davies, Dara L. Aisner, W. Patrick Devine

DOI: 10.1016/j.modpat.2026.101005

Cited by: 1

References: 29

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Cancer-related Molecular Pathways Cancer Genomics and Diagnostics

References 29